Risk factors for central nervous system involvement in non-Hodgkins-lymphoma - A multivariate analysis

被引:48
作者
Keldsen, N
Michalski, W
Bentzen, SM
Hansen, KB
Thorling, K
机构
[1] AARHUS UNIV HOSP, DEPT EXPT CLIN ONCOL, DANISH CANC SOC, DK-8000 AARHUS, DENMARK
[2] INST PATHOL, DEPT ONCOL, AARHUS, DENMARK
关键词
D O I
10.3109/02841869609084002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A consecutive cohort of patients with NHL was examined to identify the factors predictive of CNS-involvement with Cox's proportional hazards model in a multivariate analysis, Twenty-seven cases of CNS-involvement were found among 498 patients with NHL, Only 3 of 96 patients with low-grade lymphomas had CNS involvement, all occurring after transformation into high-grade lymphoma, In univariate analysis of 402 patients with intermediate or high-grade lymphoma, lymphoblastic histology (including Burkitt's lymphoma), age <35 years, B-symptoms, stage IV disease, testis involvement and bone marrow involvement were found to be statistically significant risk factors, Lymphoblastic histology was found to be strongly correlated to age younger than 35 years, In the multivariate analysis only lymphoblastic histology, stage IV disease and B-symptoms were found to be significantly associated with CNS involvement, It is concluded that CNS prophylaxis should be considered in all patients with lymphoblastic histology and in patients with stage IV B lymphomas other than those of low-grade types.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 33 条
[1]   PHASE-III TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) VERSUS CISPLATIN, ETOPOSIDE, BLEOMYCIN AND PREDNISONE (CISEBP) FOR THE TREATMENT OF ADVANCED NON-HODGKINS-LYMPHOMA OF HIGH-GRADE MALIGNANCY [J].
ANDERSEN, J ;
THORLING, K ;
BENTZEN, SM ;
BRINCKER, H ;
CHRISTENSEN, BE ;
PEDERSEN, M .
ACTA ONCOLOGICA, 1990, 29 (08) :995-999
[2]   CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN PATIENTS WITH DIFFUSE AGGRESSIVE NON-HODGKIN LYMPHOMA [J].
BASHIR, RM ;
BIERMAN, PJ ;
VOSE, JM ;
WEISENBURGER, DD ;
ARMITAGE, JO .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (06) :478-482
[3]  
BENTZEN SM, 1988, CANCER-AM CANCER SOC, V62, P194, DOI 10.1002/1097-0142(19880701)62:1<194::AID-CNCR2820620129>3.0.CO
[4]  
2-8
[5]  
BERNASCONI C, 1991, LEUKEMIA, V5, P90
[6]  
BUNN PA, 1976, BLOOD, V47, P3
[7]  
COS DR, 1972, J R STAT SOC B, V34, P187
[8]  
DIXON WJ, 1990, BMDP STATISTICAL SOF, P769
[9]  
ERSBOLL J, 1985, SCAND J HAEMATOL, V35, P487
[10]   CNS INVOLVEMENT IN SMALL NONCLEAVED-CELL LYMPHOMA - IS CNS DISEASE PER SE A POOR PROGNOSTIC SIGN [J].
HADDY, TB ;
ADDE, MA ;
MAGRATH, IT .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) :1973-1982